Eli Lilly and Company LLY 1150.99 -163.66% NYQ · Healthcare
Open terminal

Eli Lilly and Company (lly)

Unlock full data in Terminal →

LLY Dividends

Dividend yield0.59%
Forward P/E24.31

The figure above is this ticker’s indicated or trailing dividend yield. Yield means annual dividend divided by the current share price. A 12-month (TTM) yield uses dividends already paid; the forward yield uses the expected next year. Dividend yield meaning — then confirm the live payout for Eli Lilly and Company (LLY) in Vest Terminal.

Start Free — open LLY in Vest Terminal

Access live data, filings, ownership, and analysis for Eli Lilly and Company.

Create free account See plans

Eli Lilly and Company FAQ

What does Eli Lilly and Company (LLY) do?

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100,…

What is LLY's P/E ratio?

Eli Lilly and Company has a trailing P/E of 38.57× based on publicly available market data.

Does LLY pay a dividend?

Indicated dividend yield: 0.6%. Confirm ex-dates and payout history in Vest Terminal.

What sector is LLY in?

Eli Lilly and Company is classified in Healthcare (Drug Manufacturers - General) on NYQ.

What is LLY's market capitalization?

Approximate market cap: $1.03T.

What are the main risks for LLY?

Key risks include elevated valuation, among factors on this page.

What are the strengths of LLY?

Potential positives include revenue growth of 47.7% year-over-year, earnings growth of 26.2% year-over-year.

Where can I get analyst estimates for LLY?

Public analyst price targets and consensus for Eli Lilly and Company are on the free /stocks/lly/estimates page. Deeper estimate history and models are available in Vest Terminal.